Rice microbiome consortium for enhanced rice blast resistance

Technology
Conceptual
University

Harnessing a synthetic community of rice-associated microbes to enhance resistance against rice blast disease through green chemistry approaches and indirect ISR pathways.

Overview

The Rice Microbiome Consortium is an innovative solution aimed at enhancing rice blast resistance using a synthetic community of rice-associated microbes (syncom). This approach leverages the natural antimicrobial properties of these microbes to induce systemic resistance in rice plants, ultimately reducing the incidence of rice blast disease. The consortium focuses on developing green chemistry methods to cultivate rice varieties with inherent pathogen tolerance.

Technical specifications
  • Synthetic Community (Syncom): Isolated from both soil and hydroponic cultures, the syncom demonstrates strong antimicrobial activity against the rice blast pathogen.
  • Indirect Induced Systemic Resistance (ISR): The syncom enhances resistance through ISR pathways, providing a sustainable and eco-friendly alternative to chemical fungicides.
  • Active Metabolite Isolation: Efforts are underway to isolate and characterize the metabolites responsible for the observed antimicrobial activity, with the aim of developing targeted interventions.
Technology readiness level

The research is currently at Technology Readiness Level 3, indicating that the proof-of-concept has been demonstrated under controlled conditions. Future validation will involve testing different rice lines with the syncom in greenhouse settings to further assess tolerance levels and refine metabolite isolation techniques.


About University of Delaware

The University of Delaware is a comprehensive public research university and the state’s flagship, recognized for cross-disciplinary collaboration with industry. A research and technology park adjacent to campus co-locates corporate R&D with university labs and startups, with shared facilities and pilot-scale capabilities; integration with a regional health system enables clinical translation. Its Mid-Atlantic location offers quick access to talent, transportation, and nearby industrial clusters, while a statewide extension network supports testing and adoption. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, and NASA. A dedicated technology transfer office streamlines IP, licensing, and startup formation, and corporate engagement provides a single point of entry.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.